Dandelion Health

Dandelion Health, founded in 2020, supplies AI developers, life sciences companies and healthcare organisations with multimodal, de-identified real-world clinical data for building, validating and evaluating clinical AI products. Its technical work spans electronic medical record analytics, medical imaging, physiologic waveforms, continuous streaming monitoring data, de-identified data aggregation and governance, and algorithm validation and performance evaluation. The company operates in the United States and serves the healthcare, pharmaceutical, clinical research and cardiology sectors.

Its principal asset is the Digital Biobank Platform, which aggregates de-identified clinical data from multiple U.S. health systems: structured EMR data, unstructured clinical notes, medical images, waveforms, video and continuous streaming monitoring data. The platform covers more than 10m patients, with records dating back to 2016. Alongside it, the Clinical AI Marketplace connects algorithm developers with life sciences companies seeking to accelerate drug development and clinical research.

The American Heart Association AI Assessment Lab, powered by Dandelion Health, conducts independent, scientifically rigorous evaluations of cardiology and other clinical AI algorithms against real-world performance data. The company was founded by experts spanning health tech, hospital systems, academia and clinical AI, and describes an emphasis on responsible clinical AI, scientific rigour and representative, high-quality de-identified patient data.